fingolimod hydrochloride has been researched along with pirfenidone in 1 studies
| Studies (fingolimod hydrochloride) | Trials (fingolimod hydrochloride) | Recent Studies (post-2010) (fingolimod hydrochloride) | Studies (pirfenidone) | Trials (pirfenidone) | Recent Studies (post-2010) (pirfenidone) |
|---|---|---|---|---|---|
| 2,771 | 157 | 2,062 | 1,094 | 102 | 883 |
| Protein | Taxonomy | fingolimod hydrochloride (IC50) | pirfenidone (IC50) |
|---|---|---|---|
| Transforming growth factor beta-1 proprotein | Mus musculus (house mouse) | 1.43 | |
| Mothers against decapentaplegic homolog 3 | Mus musculus (house mouse) | 1.43 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Burton, JM; O'Connor, P | 1 |
1 review(s) available for fingolimod hydrochloride and pirfenidone
| Article | Year |
|---|---|
Novel oral agents for multiple sclerosis.
Topics: Administration, Oral; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Cladribine; Clinical Trials as Topic; Dimethyl Fumarate; Fingolimod Hydrochloride; Fumarates; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Immunosuppressive Agents; Interferon beta-1b; Interferon-beta; Isoxazoles; Leflunomide; Minocycline; Multiple Sclerosis; Mycophenolic Acid; Propylene Glycols; Pyridones; Quinolones; Sphingosine | 2007 |